CTRI/2021/07/034834
Recruiting
未知
A real-world observational study on Diabetes Mellitus patients administering dual combination therapy of Teneligliptin and MetformIn to evaluate REnal function. - ADMIRE STUDY
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Sponsor
- Mankind Pharma Ltd
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male or female patients, age ââ?°Â¥ 18 to ââ?°Â¤ 85 years.
- •2\. Uncontrolled Type 2 diabetes with a haemoglobin A1c (HbA1c) ââ?°Â¥7\.0 percent.
- •3\. eGFR (MDRD) at screening \> 60 mL/min/1\.73m2
- •4\. Patients who are prescribed Teneligliptin and Metformin combination therapy as part of routine clinical practice.
Exclusion Criteria
- •1\. Female patients who are pregnant or breast feeding
- •2\. Patients with known liver or kidney dysfunction
- •3\. Patients who are suspected of or known to have an intolerance to Teneligliptin or Metformin.
- •4\. Presence of any other clinically significant disease or laboratory findings that in the Investigators opinion may affect the study outcomes or continued participation of patient in the study.
- •5\. Participation in another study concurrently or within 4 weeks prior to the Screening Visit
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Prospective obserbational study of diabetes using new classifications by HLA, SNPs and biomarkersJPRN-UMIN000050579Ehime University5,000
Recruiting
Not Applicable
Multicenter Investigation for Diabetes mellitus in AtheroSclerosisPatients admitted to the participating institution for 1. Acute myocardial infarction within 24 hours after symptom onset 2. Angina pectoris requiring PCI 3. Heart failure 4. Atrial fibrillation undergoing catheter ablation 5. Cerebral infarction 6. Transient ischemic attackJPRN-UMIN000010039ational Cerebral and Cardiovascular Center5,000
Not yet recruiting
Phase 1
A research for the clinical validity of Diabetes decoction which was set up by national medical master professor Yan Dexin and was used for treating type 2 diabetes with spleen-deficiency and blood-stasis syndrome in the early periodType 2 diabetesITMCTR1900002699Shanghai Traditional Chinese Medicine Hospital
Completed
Not Applicable
Study to evaluate a smartphone application for raising diabetes risk awareness in urban IndiaISRCTN08439795nilever Discover (UK)200
Not yet recruiting
Not Applicable
Prognosis of patient with diabetes mellitusHealth Condition 1: E116- Type 2 diabetes mellitus with other specified complicationsCTRI/2021/10/037404Sudha Vidyasagar